Related Experiment Video

Updated: Aug 22, 2026

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
07:05

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis

Published on: May 17, 2015

Impact of donor-transmitted coronary atherosclerosis

Onnen Grauhan1, Roland Hetzer

  • 1Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. grauhan@dhzb.de

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|September 24, 2004
PubMed

Insights

Pre-existing coronary atherosclerosis in donor hearts worsens transplant outcomes. This condition amplifies injury from brain death, ischemia, and reperfusion, negatively impacting graft survival and patient prognosis.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Pathology

Background:

  • Donor heart shortages have led to expanded organ acceptance criteria.
  • This expansion increases the risk of transmitting atherosclerotic lesions via transplantation.
  • Coronary atherosclerosis in donor organs is a growing concern in heart transplantation.

Purpose of the Study:

  • To evaluate how pre-existing coronary atherosclerosis affects cumulative injury in transplanted hearts.
  • To determine if atherosclerosis exacerbates damage from brain death, ischemia, and reperfusion.
  • To assess the impact of atherosclerosis on heart transplant outcomes.

Main Methods:

  • Utilized retrospective analysis of heart transplant cases.
  • Assessed donor hearts for the presence and severity of coronary atherosclerosis.
  • Quantified cumulative injury markers including brain death, ischemia, and reperfusion times.
  • Correlated atherosclerosis severity with post-transplant outcomes.

Main Results:

  • Pre-existing coronary atherosclerosis significantly potentiated cumulative injury.
  • Atherosclerotic lesions amplified damage caused by ischemia and reperfusion.
  • Increased atherosclerosis severity was linked to poorer graft function and survival.

Conclusions:

  • Coronary atherosclerosis is a critical factor that worsens heart transplant outcomes.
  • Transplant protocols should consider donor coronary atherosclerosis to mitigate risks.
  • Further research is needed to optimize management of atherosclerotic donor hearts.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...